WallStreetZenWallStreetZen

NASDAQ: OACC
Oaktree Acquisition Corp III Life Sciences Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Oaktree Acquisition III Life Sciences earnings were $6.8M for the trailing 12 months ending Jun 30, 2026, with 7.4% growth year over year. The latest OACC earnings report on Jun 30, 2026 announced Q2 2026 earnings of $1.6M, up 15.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, OACC reported annual earnings of $7.3M, with 447.3% growth.

OACC past earnings growth

How has OACC's earnings growth performed historically?

Company
7.41%
Industry
51.32%
Market
93.54%
OACC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
OACC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
OACC's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

OACC earnings history

Current Revenue
$0.0
Current Earnings
$6.8M
Current Profit Margin
0%

OACC Return on Equity

Current Company
-95.6%
Current Industry
231.5%
Current Market
30.9%
OACC's Return on Equity (-95.6%)... subscribe to Premium to read more.
High Return on Equity Performance

OACC Return on Assets

Current Company
3.3%
Current Industry
-1.9%
OACC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when OACC announces earnings.

OACC Return on Capital Employed

Current Company
3.3%
Current Industry
-1.6%

OACC vs Shell Company Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OACC$6.75M$6.75M+7.41%$0.29
DMAA$6.09M$6.09M+111.11%$0.19
NTWO$4.95M$4.95M-16.67%$0.20
CATLN/AN/AN/AN/A
PNAQ.UN/AN/AN/AN/A
View Top Shell Company Stocks

Oaktree Acquisition III Life Sciences Earnings Reports & History FAQ

What were Oaktree Acquisition III Life Sciences's earnings last quarter?

Oaktree Acquisition III Life Sciences (NASDAQ: OACC) reported Q2 2026 earnings per share (EPS) of $0.07, up 12.5% year over year. Total OACC earnings for the quarter were $1.60 million. In the same quarter last year, Oaktree Acquisition III Life Sciences's earnings per share (EPS) was $0.08.

If you're new to stock investing, here's how to buy Oaktree Acquisition III Life Sciences stock.

Is Oaktree Acquisition III Life Sciences profitable or losing money?

As of the last Oaktree Acquisition III Life Sciences earnings report, Oaktree Acquisition III Life Sciences is currently profitable. Oaktree Acquisition III Life Sciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $6.75 million, a 38.84% increase year over year.

What was OACC's earnings growth in the past year?

As of Oaktree Acquisition III Life Sciences's earnings date in Q3 2026, Oaktree Acquisition III Life Sciences's earnings has grown 7.41% year over year. This is 43.91 percentage points lower than the US Shell Companies industry earnings growth rate of 51.32%. OACC earnings in the past year totalled $6.75 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.